Table 1.
Main clinical and pathological features of the cases
|
Clinical and pathological features |
No. of cases (%) (n=71) |
|
Gender |
|
|
Male |
37 (52.1) |
|
Female |
34 (47.9) |
|
Age at diagnosis [years] |
|
|
<20 |
2 (2.8) |
|
20–29 |
1 (1.4) |
|
30–39 |
3 (4.2) |
|
40–49 |
7 (9.9) |
|
50–59 |
17 (23.95) |
|
60–69 |
24 (33.8) |
|
≥70 |
17 (23.95) |
|
Tumor location |
|
|
Stomach |
10 (14.1) |
|
Duodenum |
2 (2.8) |
|
Small intestine |
10 (14.1) |
|
Appendix |
6 (8.5) |
|
Right colon |
11 (15.5) |
|
Left colon (including rectum) |
13 (18.3) |
|
Hepatic metastasis |
19 (26.7) |
|
Tumor grade |
|
|
G1 |
28 (39.4) |
|
G2 |
21 (29.6) |
|
G3 |
22 (31) |
|
Tumor type |
|
|
NET |
52 (73.2) |
|
G1 NET |
27 (38) |
|
G2 NET |
18 (25.4) |
|
G3 NET |
7 (9.8) |
|
NEC |
12 (17) |
|
SCNEC |
3 (4.25) |
|
LCNEC |
9 (12.7) |
|
MiNEN |
3 (4.2) |
|
AGCC |
4 (5.6) |
|
AGCC G1 |
1 (1.4) |
|
AGCC G2 |
1 (1.4) |
|
AGCC G3 |
2 (2.8) |
AGCC: Adenocarcinoma ex-goblet cell carcinoid; G: Grade; LCNEC: Large-cell neuroendocrine carcinoma; MiNEN: Mixed neuroendocrine non-neuroendocrine neoplasm; NEC: Neuroendocrine carcinoma; NET: Neuroendocrine tumor; SCNEC: Small-cell neuroendocrine carcinoma